On the recordDecember 9, 2019
The adequacy of FDA's oversight of the U.S. drug supply has been a longstanding issue for this committee.
Source
congress.govThe adequacy of FDA's oversight of the U.S. drug supply has been a longstanding issue for this committee.
Guthrie highlights ongoing concerns about FDA's drug supply oversight.
Share
More from Brett Guthrie
If you look at what’s going on in local communities, people are just concerned. These large loads coming into their local community, what’s it gonna do to their rates … And so that I think it opens up the opportunities for data centers to…
I hope he recovers. He’s been a mentor of mine and a friend of mine since I ran for the state Senate a few years ago. And so my thoughts and prayers are with him.
We’re not competing with Europe to regulate. We’re competing with China to regulate.
It is an important milestone — not a finish line — in the effort to better protect children online.